Celon Pharma
CLN.WA
#8822
Rank
NZ$0.39 B
Marketcap
NZ$7.38
Share price
-0.25%
Change (1 day)
-29.78%
Change (1 year)

EPS for Celon Pharma (CLN.WA)

EPS in 2026 (TTM): NZ$0.90

According to Celon Pharma's latest financial reports the company's current EPS (TTM) is NZ$0.93. In 2025 the company made an earnings per share (EPS) of NZ-$0.75 a decrease over its 2024 EPS that were of NZ-$0.28.

EPS history for Celon Pharma from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.90-219.43%
2025NZ-$0.75166.21%
2024NZ-$0.2811.22%
2023NZ-$0.25-20.64%
2022NZ-$0.32186.32%
2021NZ-$0.111047.74%
2020NZ-$0.009766-107.56%
2019NZ$0.13-59.53%
2018NZ$0.327.36%
2017NZ$0.30-18.58%
2016NZ$0.37-5.31%
2015NZ$0.39